The Psychotherapist Association for
Gender & Sexual Diversity

2019 Annual Members Meeting & "Ketamine in Psychiatry and Psychotherapy" CE Program

  • April 14, 2019
  • 10:00 AM - 3:00 PM (PDT)
  • UCSF Alliance Health Project, 1930 Market Street, San Francisco
  • 2

Registration


Registration is closed

Please make sure to join us for our 2019 Annual Meeting on Sunday, April 14th at the UCSF Alliance Health Project, 1930 Market St. in San Francisco (Market & Guerrero, close to the Church St. MUNI Station, and a 5-10 minute walk from 16th/Mission BART). 

The meeting will consist of two parts.  Our member mixer and business meeting, from 10:00am-1:00pm (including lunch), followed by a CE program from 1:00-3:00pm (Raquel Bennett, PsyD, presenting "Ketamine in Psychiatry and Psychotherapy").  

At our Annual Meeting, we will discuss our financial and organizational status, review the past year and look toward Gaylesta's future. As a part of this meeting we will nominate and elect our 2019/2020 board. Gaylesta will have several openings in the upcoming term. Board service will allow you to take a more active role in the direction of the organization and help propel our organization, our members and the greater LGBTQ communities forward. It's a wonderful opportunity to network with like minded clinicians, increase your knowledge of board service in general and enhance your CV. If you have questions, feel free to reach out to any current board member or simply bring your questions to the meeting. The meeting is also a great opportunity to meet and mingle with colleagues while being able to share your thoughts about Gaylesta's future while networking your own practice.

Ketamine in Psychiatry and Psychotherapy

For the CE component of the day (2 CEUs detailed information available here), Dr. Raquel Bennett will give an overview of the field of therapeutic ketamine, including different ways of working with ketamine for depression, including low-dose infusions, ketamine-facilitated psychotherapy, and psychedelic ketamine journeys. She will also talk about which patients are appropriate for ketamine treatment and which patients would not be a good fit for this approach, according to the most current medical literature. In addition, Dr. Bennett will talk briefly about the pharmacology of ketamine and legal considerations about working with it in clinical practice.  Please note that this is an introductory level presentation, and not a comprehensive training.

Continuing Education Information
Gaylesta: The Psychotherapist Association for Gender and Sexual Diversity, is approved by the American Psychological Association to sponsor continuing education for psychologists.  Gaylesta maintains responsibility for this program and its content.  [APA approved 
CE units may also be credited to other licensed mental health professionals, such as LCSWs, LPCCs, and LMFTs. CE credit will only be awarded for full attendance.]